Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TrialsWest operates as one of Australia’s most experienced clinical research centres. It partners with global pharmaceutical and biotechnology companies to conduct clinical trials that help bring new medicines and vaccines to market. The company was acquired by Resonance Health in mid–2024 but continues to operate under its own brand with the founding leadership team remaining in place. It contributes approximately A$2 million in annual revenue and A$0.67 million EBITDA based on FY24 projections. The acquisition aims to expand both the number of trial sites operated by TrialsWest and the breadth of services offered.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TrialsWest.